Loading stock data…
CAH
$212.67+8.19 (+4.01%)
After Hours$212.57-0.10 (-0.05%)· Last close Jun 9
Cardinal Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardinal Health, Inc. in the Healthcare sector is trading at $212.67 with a market capitalization of $45.9B. Wall Street consensus targets $245.27 (15 analysts), implying a +15.3% move over the next 12 months. The stock is currently 9% below its 52-week high of $233.60, remaining 9.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +15.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$212.67
Potential Downside
23%
Whystock Fair Value$163.68
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Mean target$245.27+15.3%
Range$215.00 – $275.00
Fundamentals
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$45.87B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.90
Beta
Defensive asset. Lower volatility than the S&P 500.
0.54
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.96%
ROE
Average efficiency. Growth may require heavy reinvestment.
-54.91%
Volume
Today's trading volume
2.78M
Recent News
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.
How The Mixed Analyst Calls Are Reframing The Cardinal Health (CAH) Investment Story
Cardinal Health is back in focus as fresh Street research reshapes the price target conversation, with several firms trimming their targets while one raises its view and another starts coverage on a bullish footing. Those mixed calls reflect a split between analysts who see room for upside if execution holds and others who are more cautious about how much to pay for the stock right now. As you read on, you will see how to track these shifting views and what they might mean for your own...
Why Coca-Cola and Walmart Top This List of Steady, Low-Volatility Dividend Aristocrats
Dividend Aristocrats can offer income, stability, and consistency. Here are four lower-volatility names analysts still like.
Stocks Rebound on Strength in Banks and Managed Healthcare
The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. June E-mini S&P futures (ESM26 ) rose +0.36%, and June E-mini Nasdaq futures...
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.